Medication info

Entipozine 5/160 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Korea Sintax Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging X2)
Approval status
Expired

MFDS item code 201907811 · Approved 2019.11.08

This product's status changed to Expired on 2024.11.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, direct switching to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using an individual component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
Patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients.

Ingredients

Manufacturer
Korea Sintax Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or valsartan alone.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, direct switching to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using an individual component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

Patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; thus, it should not be taken by women who are pregnant or may become pregnant. Additionally, it should not be used by patients with known allergies to its components, severe kidney or liver disease, or certain heart conditions. Patients with sodium or fluid depletion may experience hypotension, so their condition should be carefully monitored before and during use, including blood pressure monitoring. Patients with hyperkalemia who take this medication alongside drugs that can raise potassium levels should have their potassium levels frequently checked. Patients with renal artery stenosis or those who have recently undergone kidney transplantation should closely monitor kidney function while taking this medication. If symptoms of angioedema occur, the medication should be discontinued immediately, and patients recovering from heart failure or myocardial infarction should use caution, closely monitoring kidney function and symptoms. Dizziness or fatigue may occur during operation of vehicles or machinery, so caution is required. This medication may impact kidney function or electrolyte balance when used in combination with other antihypertensive drugs, and regular check-ups should be conducted per the physician's instructions. Moreover, patients with compromised liver function may require dosage adjustments, and overdose may lead to hypotension or cardiac issues requiring immediate emergency treatment. The safety and efficacy of this medication in children under 18 years old have not been adequately established, hence its use is not recommended. Finally, nursing mothers are advised to avoid taking this medication.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, local edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory decrease, taste distortion, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbance, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervous tension, sensory decrease, Stevens-Johnson syndrome, dizziness, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the drug's effectiveness.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging X2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.